Nigeria - FY 2009 Approved Funding by Program Area, Agency and Funding Source
*Only appropriations from the GHCS (State) fund account are notified by the Global AIDS Coordinator.
In a complex environment, PEPFAR Nigeria is contributing important progress towards key results in the nation's fight against the epidemic. Nigeria has met its treatment goals, providing over 200,000 persons with ART in FY 2008. The team is successfully using spatial distribution data of HIV in the population to design and tailor interventions to respond to the epidemic throughout this large country. There is excellent coverage of PMTCT activities with over one million women receiving counseling and testing and PMTCT services, and gender is addressed throughout the USG PEPFAR activities.
In FY 2009 prevention activities in Nigeria will be incorporated into all care and treatment activities and will include PMTCT, prevention of sexual transmission, and prevention of medical transmission, including blood and injection safety. PEPFAR will continue its efforts to expand coverage of PMTCT services to pregnant women across Nigeria by leveraging resources for laboratory commodities for EID and therapeutic feeding products for pregnant and lactating women. Mass media messages, such as the popular and successful national "ZIP UP" campaign, will continue, as will capacity-building to local civil society organizations, NGOs, and FBOs to deliver accurate, high-quality ABC messages. The couples counseling program will expand and continue to provide targeted prevention messages for discordant couples. Efforts to reduce new infections among high-risk and high-transmission communities will continue, with messages specifically targeted for each individual risk group. PEPFAR will provide syndromic management services for sexually transmitted infections to persons engaged in high-risk behaviors to help prevent HIV infection.
Care programs in Nigeria have also shifted their focus to ensuring the maintenance of all supported clients receiving care and treatment services, including OVC. In FY 2009, care activities in Nigeria will include CT, adult and pediatric care and support, TB/HIV collaborative programs, and support for OVCs. All USG CT partner activities have incorporated Nigeria's nationally recognized CT campaign, branded Heart-to-Heart, and are used to deliver prevention messages, care referral, and treatment to those found to be HIV-positive. In FY 2009 PEPFAR will continue to support care for all HIV-positive individuals identified, including management of STIs and OIs, laboratory follow-up services, and referrals to a care network. People affected by HIV/AIDS will also receive support services, home-based care kits, and access to psychosocial support. Children remain a priority with an increased focus on PMTCT outcomes; provision of EID; prioritization of scale-up of treatment services to children; provision of pediatric tuberculosis services; prevention initiatives focused on school-aged children; nutrition and education programs; and direct services for OVC and their care providers.
Treatment activities in Nigeria will include the provision of ARV drugs and services to eligible patients, as well as laboratory support for the diagnosis and monitoring of HIV-positive patients identified through PEPFAR activities. ART programs will purchase FDA-approved or tentatively approved ARV drugs, in their generic formulation whenever possible, in an effort to maximize the number of Nigerians receiving treatment. In FY 2009, PEPFAR is beginning a phased approach to pool ARV drug procurements and distribution through SCMS. This method, based on PEPFAR-wide forecasting, will decrease duplication efforts by individual partners and increase shipping efficiency through use of sea/road transportation. Integral to the provision of treatment services, laboratories will focus on maintaining services through the implementation of expanded and harmonized lab quality assurance and quality control systems. In addition, the USG will continue to emphasize networking of care with a tiered approach to laboratory equipment platforms for HIV clinical monitoring and service delivery. USG-supported labs will continue to scale-up support for the implementation of a national network for early infant diagnosis.
Funds will be used to support a collaboration and negotiation process with the Government of Nigeria (GON) to define the policy reform, financial sustainability and program coordination elements to which the GON will be a signatory in its PEFPAR Partnership Framework.
| U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator|
and the Bureau of Public Affairs, U.S. State Department.
External Link Policy | Copyright Information | Privacy | FOIA